MLICM
ZYNE

Metropolitan Life Insurance Company (MetLife)’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,751
Closed -$23.7K – 2639
2019
Q2 		$23.7K Buy
+1,751
New +$23.7K ﹤0.01% 2584